ХУҚУҚ ВА ИҚТИСОДИЁТ
6. Bhate Hanum S. Y.M., Nasrul E., Jusuf N.K., Yeriza E. The Effect of Forkhead Box Class O1, Mammalian Target of Rapamycin
Complex 1, Survivin, and Interleukin-17 on the Degree of Acne Vulgaris Based on Serum Levels. Open Access Macedonian
Journal of Medical Sciences. 2020 Feb 05; 8(B):401-407.
7. Demirbaş A, Elmas ÖF. The relationship between acne vulgaris and irritable bowel syndrome: A preliminary study. J Cosmet
Dermatol 2020. 2021 Jan;20(1):316-320.
8. Dréno B., 2017; Xu H. Li H. 2019K., Williams H.C., 2013; Janani, S., Sureshkumar, R. A., 2019.
9. Dunn L.K. Acne in adolescents: quality y of life, mood, and psychological disorders / L.K. Dunn, J.L. O’Neill, S.R. Feldman
// Dermatol. Online J. - 2011. -Vol. 17-№ l.-P. 1.
10. El GaremY. F., Ahmed R. A., Ragab M. A. et al. Study of oxidative stress in different clinical severities of acne vulgaris.
Egypt J Dermatol Venerol. 2014; 34:53-57.
11. Hanna S. Acne vulgaris: more than skin deep / S. Hanna, J. Sharma, J. Klotz // Dermatol Online J. - 2003. - Vol. 9. - № 3. - P. 8.
12. Hanum S. Y.M., Nasrul E., Jusuf N.K., Yeriza E. The Effect of Forkhead Box Class O1, Mammalian Target of Rapamycin
Complex 1, Survivin, and Interleukin-17 on the Degree of Acne Vulgaris Based on Serum Levels. Open Access Macedonian
Journal of Medical Sciences. 2020 Feb 05; 8(B):401-407.
13. Jafferany, M. The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders:
results of a survey study. Int J Dermatol. – 2010. – Jul; 49 (7). – P. 784-9.)
14. Kellett, S. The psychological and emotional impact of acne and the effect of treatment with isotretinoin / S. Kellett, D.
Gawkrodger // Br J Dermatol. – 1999. – Feb; Vol. 140 (2). – P. 273-82.
15. Kirsten N., Mohr N., Augustin M. Prevalence and Cutaneous Comorbidity of Acne Vulgaris in the Working Population.
Clinical, Cosmetic and Investigational Dermatology 2021:14 1393–1400
16. Kokandi, A. Evaluation of Acne Quality of Life and Clinical Severity in Acne Female Adults / A. Kokandi// Dermatology
Research and Practice. – 2010. – 2010: 410809)
17. Niemeier V, Kupfer J, Demmelbauer-Ebner M, et al. Coping with acne vulgaris: evaluation of the chronic skin disorder
questionnaire in patients with acne. Dermatology. 1998;196:108-115.
18. Picardi A, Mazzoti E, Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad
Dermatol. 2000;54:420-426.
19. Picardi A. , Amerio P. , Baliva G. , et al. (2004) в 7,6% случаев (Picardi A. , Amerio P. , Baliva G. , et al. // Acta Derm
Venereol. – 2004. – Vol. 84 (3). – P. 213-7.
20. Plewig G., Kligman A. M. Acne and Rosazea. - Berlin: Springer-vertag, 2000. - 744 р
21. Purvis D., Robinson E., Merry S., Watson P. Acne, anxiety, depression and suicide in teenagers: a crosssectional survey
of New Zealand secondary school students. // J Paediatr Child Health. – 2006. – Dec; Vol. 42 (12). – P. 793-6.
22. Sugisaki H., Yamanaka K., Kakeda M. et al. Increased interferon-[gamma], interleukin-12p40 and IL-8 production in Propioni
bacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: Host response but not bacterial
species is the determinant factor of the disease. Journal of Dermatological Science. 2009 Jul; 55(1): 47-52.
23. Suva1 M. A., Patel A. M, Sharma N. et al. A Brief Review on Acne Vulgaris: Pathogenesis, Diagnosis and Treatment. 2016
Volume 4, Issue 3: 1-12.
24. Tanghetti Emil A. The Role of Inflammation in the Pathology of Acne. J Clin Aesthet Dermatol. 2013 Sep; 6(9): 27–35.
25. Thiboutot D., Gollnick H., Bettoli V., et al; Global Alliance to Improve Outcomes in Acne. New insights into the management
of acne: an update from the Global Alliance to Improve Outcomes in Acne Group. J Am. Acad. Dermatol. 2009; 60 (suppl
5):S1-50.
Do'stlaringiz bilan baham: |